Boryung Pharmaceutical Co., Ltd
Clinical trials sponsored by Boryung Pharmaceutical Co., Ltd, explained in plain language.
A South Korean pharmaceutical company producing prescription drugs and consumer health products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Diabetes drug switch: could a new combo improve blood sugar? Results expected Oct 2026 (estimated)
- New chemo formula may reduce Alcohol-Like reactions in breast cancer patients Results expected Oct 2026 (estimated)
- New pill aims to tame high blood pressure in 8 weeks Results expected Feb 2027 (estimated)
- Colon cancer study aims to improve treatment for older patients Results expected Feb 2027 (estimated)
- New dosing strategy for schizophrenia drug aims to cut side effects Results expected May 2027 (estimated)